BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35281030)

  • 1.
    Meng Z; Chen Y; Wu W; Yan B; Zhang L; Chen H; Meng Y; Liang Y; Yao X; Luo J
    Front Immunol; 2022; 13():754645. PubMed ID: 35281030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma.
    Lei S; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107816. PubMed ID: 34162166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
    Yang B; Gu A; Wu Y
    Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormally expressed JunB transactivated by IL-6/STAT3 signaling promotes uveal melanoma aggressiveness via epithelial-mesenchymal transition.
    Gong C; Shen J; Fang Z; Qiao L; Feng R; Lin X; Li S
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29899166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An autophagy-related prognostic signature associated with immune microenvironment features of uveal melanoma.
    Zheng Z; Zhang L; Tu Z; Deng Y; Yin X
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33682883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
    Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J
    Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analyses identify potential prognostic markers for uveal melanoma.
    Ni Y; Zhang Z; Chen G; Long W; Tong L; Zeng J
    Exp Eye Res; 2019 Oct; 187():107780. PubMed ID: 31469983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis.
    Wang J; Liu M; Sun J; Zhang Z
    J Cancer Res Clin Oncol; 2024 Jan; 150(1):23. PubMed ID: 38246894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma.
    Hu Y; Cai J; Ye M; Mou Q; Zhao B; Sun Q; Lou X; Zhang H; Zhao Y
    Front Immunol; 2022; 13():1037128. PubMed ID: 36466923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of a CCL18-related signature for prediction of overall survival in patients with uveal melanoma.
    Yang B; Fan Y; Chen M; Tang L; Tang X; Li H; Gu A; Liang R; Wu Y
    Exp Eye Res; 2023 May; 230():109448. PubMed ID: 36967081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-gene-based prognostic model predicts overall survival in patients with uveal melanoma.
    Wan Q; Tang J; Lu J; Jin L; Su Y; Wang S; Cheng Y; Liu Y; Li C; Wang Z
    Cancer Biomark; 2020; 27(3):343-356. PubMed ID: 31903983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Survival-Related Metabolic Genes and a Novel Gene Signature Predicting the Overall Survival for Patients with Uveal Melanoma.
    Guo X; Yu X; Li F; Xia Q; Ren H; Chen Z; Xing Y
    Ophthalmic Res; 2022; 65(5):516-528. PubMed ID: 35390784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative analysis identifies key genes related to metastasis and a robust gene-based prognostic signature in uveal melanoma.
    Lei S; Zhang Y
    BMC Med Genomics; 2022 Mar; 15(1):61. PubMed ID: 35300699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and verification of a hypoxia-related nine-gene prognostic model in uveal melanoma based on integrated single-cell and bulk RNA sequencing analyses.
    Zhang X; Qiu J; Huang F; Han P; Shan K; Zhang C
    Exp Eye Res; 2022 Oct; 223():109214. PubMed ID: 35981602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of prognostic genes in uveal melanoma microenvironment.
    Luo H; Ma C
    PLoS One; 2020; 15(11):e0242263. PubMed ID: 33196683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and validation of a novel prognostic signature for uveal melanoma based on five metabolism-related genes.
    Zhao H; Chen Y; Shen P; Gong L
    Math Biosci Eng; 2021 Sep; 18(6):8045-8063. PubMed ID: 34814288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data.
    Wang W; Zhao H; Wang S
    Front Immunol; 2023; 14():1099071. PubMed ID: 36793711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-137 targets EZH2 to exert suppressive functions in uveal melanoma via regulation of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition.
    Zhang J; Liu G; Jin H; Li X; Li N; Yin Q; Hu R
    J BUON; 2021; 26(1):173-181. PubMed ID: 33721449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALKBH5-mediated m
    Hao L; Yin J; Yang H; Li C; Zhu L; Liu L; Zhong J
    Aging (Albany NY); 2021 Jan; 13(3):4045-4062. PubMed ID: 33428593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.